InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Share Price

DELISTED - Current share price for API : $1.530

API General Information +

ASX Code API
Website N/A
Industry/Sector Health Care Distributors
Market Cap ($M) n/a
API Share Price $1.530
Day High $1.530
Day Low $1.528
Last Close $1.530
API Share Price Movement - ( No change )
Prices as at 16:36, 4 Apr 2022
+Security prices are delayed by at least 20 minutes and are indicative only.

Australian Pharmaceutical Industries Limited (API) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 3¢ 100% 24 Mar 2022 29 Mar 2022 - - -
HFResult 2¢ 100% 11 Nov 2021 15 Dec 2021 - - -
Result 1.5¢ 100% 6 May 2021 4 Jun 2021 - - -

See all dividends from Australian Pharmaceutical Industries Limited (API) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Australian Pharmaceutical Industries Limited (API) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - Removal from Official List 1 Apr 2022 9:02AM $1.530 $1.530 fallen by 0%
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - WES: Completion of API acquisition 31 Mar 2022 3:03PM $1.530 $1.530 fallen by 0%
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - Implementation of Scheme of Arrangement 31 Mar 2022 2:31PM $1.530 $1.530 fallen by 0%
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - Notification of cessation of securities - API 29 Mar 2022 3:35PM $1.530 $1.530 fallen by 0%
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - Change of Director's Interest Notice 29 Mar 2022 3:24PM $1.530 $1.530 fallen by 0%
Australian Pharmaceutical Industries Limited (API)
ORDINARY FULLY PAID
 Health Care - Notification of cessation of securities - API 29 Mar 2022 3:16PM $1.530 $1.530 fallen by 0%

API Directors

Name Position Start Date
Mr Richard Craig Vincent Chief Executive Officer, Managing Director 15 Feb 2017

Australian Pharmaceutical Industries Limited (API) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
29 Mar 2022 VINCENT, Richard Cancelled Related Securities 2,213,741 $1.550 $3,431,298.550
14 Dec 2020 MACDONALD, Jennifer (Jenny) Buy Direct Shares 25,000 $1.305 $32,625.000
24 Apr 2020 SMITH, Mark Buy Indirect Shares 40,000 $1.039 $41,550.000

See all changes in directors' interest & trades for Australian Pharmaceutical Industries Limited (API) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

API Management

Name Position
Peter Mendo Chief Financial Officer
Anne Mustow Company Secretary,General Counsel

API Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (API). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
95,068,472 (19.08%) Wesfarmers Limited
38,359,203 (7.70%) First Sentier Investors Holdings Pty Ltd
38,360,947 (7.70%) Mitsubishi UFJ Financial Group, Inc

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.